Minimally invasive management of chronic venous insufficiency: A case report on combined radiofrequency ablation and sclerotherapy in an obese patient

慢性静脉功能不全的微创治疗:一例肥胖患者射频消融联合硬化疗法的病例报告

阅读:1

Abstract

INTRODUCTION: Chronic venous insufficiency (CVI) affects a significant portion of the population, particularly impacting those with obesity. This condition leads to various symptoms, including leg discomfort and edema, contributing to work absenteeism. Traditional surgical procedures, like saphenous vein stripping and phebectomy, are increasingly supplanted by minimally invasive techniques, such as radiofrequency ablation (RFA) and sclerotherapy, which reduce invasiveness and associated complications, particularly beneficial for high-risk patients, including those with obesity. CASE PRESENTATION: A 22-year-old male patient with a BMI of 41, suffering from severe varicose veins, hypertension, diabetes, and obstructive sleep apnea. The patient underwent simultaneous RFA and sclerotherapy after imaging confirmed significant venous incompetence but ruled out deep vein thrombosis. The procedure, performed under spinal anesthesia, resulted in successful obliteration of the great saphenous vein, with no postoperative complications. CLINICAL DISCUSSION: The literature highlights the advantages of endovascular techniques over traditional open surgery, particularly for patients with comorbidities that elevate surgical risks. Studies support the efficacy of combining RFA with sclerotherapy, showing improved outcomes and reduced recurrence rates. This combined approach minimizes complications and provides a quicker recovery, making it a suitable option for high-risk patients. CONCLUSION: Our experience and the findings of literature suggest that radiofrequency ablation paired with sclerotherapy is an effective treatment modality for managing CVI, particularly in patients with obesity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。